Bank of New York Mellon Corp - ALEXZA PHARMACEUTICALS INC ownership

ALEXZA PHARMACEUTICALS INC's ticker is ALXA and the CUSIP is 015384209. A total of 43 filers reported holding ALEXZA PHARMACEUTICALS INC in Q4 2013. The put-call ratio across all filers is 0.04 and the average weighting 2.2%.

Quarter-by-quarter ownership
Bank of New York Mellon Corp ownership history of ALEXZA PHARMACEUTICALS INC
ValueSharesWeighting
Q1 2016$17,000
-29.2%
35,767
+5.1%
0.00%
Q4 2015$24,000
-44.2%
34,022
-1.7%
0.00%
Q3 2015$43,000
+16.2%
34,611
+1.7%
0.00%
Q2 2015$37,000
-46.4%
34,022
+1.2%
0.00%
Q1 2015$69,000
+38.0%
33,612
+0.5%
0.00%
Q4 2014$50,000
-35.9%
33,4450.0%0.00%
Q3 2014$78,000
-74.5%
33,445
-50.0%
0.00%
Q2 2014$306,000
+106.8%
66,890
+100.2%
0.00%
Q1 2014$148,000
+15.6%
33,419
+23.7%
0.00%
Q4 2013$128,000
-53.6%
27,017
-50.0%
0.00%
Q3 2013$276,000
+135.9%
54,034
+100.0%
0.00%
Q2 2013$117,00027,0170.00%
Other shareholders
ALEXZA PHARMACEUTICALS INC shareholders Q4 2013
NameSharesValueWeighting ↓
LANSDOWNE PARTNERS AUSTRIA GMBH 1,355,255$6,410,000100.00%
FORTALEZA ASSET MANAGEMENT INC/ 142,180$673,0000.34%
Lombard Odier & Cie (Bahamas) Ltd 44,000$208,0000.08%
HOWARD HUGHES MEDICAL INSTITUTE 98,914$468,0000.07%
KENNEDY CAPITAL MANAGEMENT LLC 476,645$2,255,0000.04%
BBT Capital Management, LLC 118,033$558,0000.02%
ROCKY MOUNTAIN ADVISERS, LLC 350$2,0000.02%
Jefferies Group LLC 520,400$2,461,0000.02%
Granite Point Capital Management, L.P. 16,574$78,0000.01%
Compagnie Lombard Odier SCmA 55,000$260,0000.01%
View complete list of ALEXZA PHARMACEUTICALS INC shareholders